menu toggle
As we continue to evolve our brand to Cencora, you will continue to see visual changes. We will be sunsetting amerisourcebergen.com over time and are actively moving content and information over to cencora.com. Please visit cencora.com if you can't find what you are looking for here.
Visit Cencora

How to optimize the commercial supply chain for cell and gene therapies

By AmerisourceBergen

In this brief, you'll get highlights from AmerisourceBergen and TrakCel experts and fast facts on optimizing the commercial supply chain. Think of it like Cliff's Notes for important ideas in the CGT space.


Enter your information below to download a PDF.
Topics:
Cell and gene therapy Commercial supply chain Commercialization

Related Content

Manufacturers

Recap Asembia 2023: Our impactful contributions to the premier specialty pharmacy conference

Inverted color AmerisourceBergen icon
AmerisourceBergen
May 2023
Amerisourcebergen representatives at Asembia

Manufacturers

Webinar: Commercial supply chain strategies for cell and gene therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2021
Commercial supply chain strategies for cell and gene therapies

Manufacturers

Webinar | Cell and gene therapies: Clinical supply chain considerations

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2021
optimal cell and gene therapy supply chain and tracking outcomes